Polish integrated pharmaceutical and biotechnology company founded in 2002 and based at Kiełpin near Łomianki north of Warsaw, listed on the Warsaw Stock Exchange. Develops and manufactures generic and innovative medicines, with a strong position in inhaled respiratory products and its own dry powder inhaler technology, and runs drug discovery programmes in central nervous system disease, metabolic disease, oncology and inflammation from its research centre.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen